· Currently commercialized ECM products are derived from animals such as cows and pigs. · Xenogeneic ECM has a complicated manufacturing process for immune evasion.
Target
· Stem cell-based decellularization medical device · Dental filler that can be used during implant surgery
· Extracellular vesicles released from cells · Used as a means of communication and molecular transport between cells and can be used for therapeutic purposes · Small size makes it easy to transplant into the body. Similar effects can be expected without direct transplantation of cells through the paracrine effect.
· Currently commercialized ECM products are derived from animals such as cows and pigs. · Xenogeneic ECM has a complicated manufacturing process for immune evasion.
Target
· Stem cell-based decellularization medical device · Dental filler that can be used during implant surgery
Organoid Exosome/Ingredient
Exosome
· Extracellular vesicles released from cells · Used as a means of communication and molecular transport between cells and can be used for therapeutic purposes · Small size makes it easy to transplant into the body. Similar effects can be expected without direct transplantation of cells through the paracrine effect.
Head Office
2nd Floor, Room 203, 240-39 Changgyeonggung-ro, Jongno-gu, Seoul, South Korea
(Gwangwon Building, Myeongnyun 4-ga)
TEL +82-2-742-0032 FAX +82-2-764-7300
Yeongeon Office
Room 501, Biomaterials Research Building, 101 Daehak-ro, Jongno-gu, Seoul, South Korea (Seoul National University School of Dentistry)
TEL +82-2-740-8641 FAX +82-2-742-8666
Munjeong Office
Room 523, Building B, 167 Songpa-daero, Songpa-gu, Seoul, South Korea (Teratower, Munjeong Station)
TEL +82-2-742-0032 FAX +82-2-764-7300
Corporate Research Institute
Rooms 513–515, Building B, 167 Songpa-daero, Songpa-gu, Seoul, South Korea (Teratower, Munjeong Station)
PIPELINE
